NYSE · Analyst Forecast

AbbVie Inc. (ABBV) Stock Forecast & Price Target

$294.69 NYSE: ABBV Market Cap $520.90B

Price as of Nov 16, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 11, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering AbbVie Inc. (ABBV), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For AbbVie Inc., analysts forecast revenue rising from $60.97B in 2025 to $86.11B in 2030; the average estimate for 2030 earnings per share is $21.17; with published estimates ranging from $20.62 to $21.71; 23 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$294.69
Consensus targetThe average of the price targets analysts have published.$308.88
Median targetThe middle target, less affected by a single outlier.$315.00
Highest targetThe most optimistic published target.$340.00
Lowest targetThe most pessimistic published target.$235.00
Difference from priceHow far the consensus target sits from today’s price.+4.8%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$60.89B$60.97B$61.02B18
2026$67.49B$67.69B$67.92B18
2027$71.66B$73.72B$75.13B19
2028$75.70B$79.44B$83.27B23
2029$82.35B$84.04B$85.69B11
2030$84.38B$86.11B$87.79B11

Earnings per share forecast

YearLowAverageHighAnalysts
2025$9.89$9.94$10.0518
2026$13.89$13.97$14.1318
2027$15.59$16.31$16.6819
2028$15.13$18.03$21.4023
2029$19.31$19.83$20.3311
2030$20.62$21.17$21.7111

AbbVie Inc. (ABBV) forecast — frequently asked questions

What is the analyst price target for AbbVie Inc.?

Analysts covering AbbVie Inc. (ABBV) have a consensus price target of $308.88, 4.8% above the current price of $294.69. Published targets range from $235.00 to $340.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for AbbVie Inc.'s earnings?

The average analyst estimate for AbbVie Inc. (ABBV) earnings per share in 2030 is 21.17, with individual estimates between 20.62 and 21.71.

How much revenue is AbbVie Inc. expected to make?

Analysts forecast AbbVie Inc. (ABBV) revenue of $86.11B in 2030, based on 11 published estimates.

How many analysts cover ABBV?

23 analysts contribute estimates for AbbVie Inc. (ABBV). Thin coverage makes an average less reliable.

Analyst forecasts for other Drug Manufacturers - General stocks

LLY forecastJNJ forecastMRK forecastNVS forecastAZN forecastAMGN forecastGILD forecastNVO forecastPFE forecastBMY forecastAll Drug Manufacturers - General stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.